Ridgeback Capital Investments L.P.

Q4 2013 13F-HR Holdings

Location
New York, NY
Holdings as of
12/31/2013
Date filed
5/15/2014
Form type
13F-HR
Num holdings
5
Total value ($000)
$79,125
Net value change ($000)
—
New positions
5
Sold out positions
0
Turnover %
100.0%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 5/15/2014 Next filing: 8/14/2026 SEC filing

Snapshot: Change Analysis

Compared to previous filing: —
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
SGMO 40,281 —
CLDX 24,815 —
STEMLINE THERAPEUTICS INC 9,931 —
Arrowhead Pharma Inc 3,031 —
GERN 1,067 —
Top Reduces (Value $000, Stocks/ETFs)
—
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type